Acute myocarditis arising in a patient with cardiac sarcoidosis presents a clinically distinct scenario. The granulomatous infiltrative process underlying cardiac sarcoidosis directly informs the choice and structure of immunosuppressive therapy.
This protocol applies to acute myocarditis occurring in the context of cardiac sarcoidosis — a condition in which granulomatous inflammation of the myocardium necessitates a tailored immunosuppressive approach distinct from standard myocarditis management.
The strategy in this setting centres on steroid-sparing immunosuppression, with a designated preferred first-line agent.
DOI: 10.1093/eurheartj/ehaf192
View source ↗